Skip to main content
Vincent Rowe, MD, Vascular Surgery, Los Angeles, CA

VincentLRoweMD

Vascular Surgery Los Angeles, CA

Professor and Chief, Division of Vascular and Endovascular Surgery David Geffen School of Medicine at UCLA

Dr. Rowe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rowe's full profile

Already have an account?

  • Office

    200 UCLA Medical Plz Ste 526
    Los Angeles, CA 90095
    Phone+1 310-206-1182
    Fax+1 310-206-1182

Education & Training

  • University of Tennessee Medical Center at Knoxville
    University of Tennessee Medical Center at KnoxvilleFellowship, Vascular Surgery - Independent, 1997 - 1999
  • Kaiser Permanente Southern California (Los Angeles)
    Kaiser Permanente Southern California (Los Angeles)Residency, Surgery, 1991 - 1996
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2026
  • American Board of Surgery Surgery
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Super Doctor SuperDoctors.com
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Non-Autogenous Conduits for Vascular Access: What's New? 
    Los Angeles, CA - 10/28/2014

Press Mentions

  • BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSV
    BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSVJanuary 23rd, 2023
  • WVS 2021: Western Vascular Society Names New President-Elect
    WVS 2021: Western Vascular Society Names New President-ElectOctober 19th, 2021
  • A 20-Second Test to Predict Risk of Major Adverse Events After Surgery
    A 20-Second Test to Predict Risk of Major Adverse Events After SurgeryNovember 25th, 2020

Professional Memberships